UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Cutting expenses in your 20s can significantly improve your financial situation. Explore practical strategies to save more and spend wisely.
18,239 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Snowflake closes its first full year under new CEO Sridhar Ramaswamy with solid revenue gains and a bold AI strategy,...
Markets move to risk-off mode as geopolitical threats push U.S. stock futures sink. Traders weigh energy prices, infl...
Beyond Meat faces a double headwind: a tepid forecast and a crowded protein-drink market. Investors are reeling as re...
AI-driven threats are accelerating demand for security software, and a trio of under-$30 cyber names could offer mean...
The Kiplinger Letter argues that most GDP growth celebrated in Washington isn’t driven by AI, a claim with sharp impl...
Authorities say fake social media campaigns lured thousands into buying the Solana-based CatFi memecoin before the cu...
A lightweight but powerful AI platform is emerging as the newest winner cheaper than Anthropic, with early profitabil...
A leading hedge fund investor says the current AI rally is fundamentally different from the late-1990s bubble, citing...
Taiwan Semiconductor Manufacturing Co. is trading at a valuation many investors describe as dirt cheap as AI-driven d...
Microsoft’s stock has fallen out of step with broader AI enthusiasm as Copilot results lag and cloud growth cools, le...
Palantir’s stock bounces back in early July after a rough June, with analysts pointing to AI-led growth and renewed d...